Activated clotting time for anticoagulation management during catheter ablation of left atrial arrhythmias: Comparison of point-of-care devices in clinical routine
Authors:
Open Access
- 19 March 2025
- journal article
- Published by Elsevier in Heart Rhythm O2
- Vol. 6 (6) , 903-905
Abstract
No abstract availableKeywords
Funding Information
- Abbott Pharmaceuticals
This publication has 8 references indexed in Scilit:
- ACT targets during atrial fibrillation ablationHeart Rhythm, 2024
- 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillationHeart Rhythm, 2024
- 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillationEP Europace, 2024
- A comparative analysis of four activated clotting time measurement devices in cardiac surgery with cardiopulmonary bypassPerfusion, 2020
- Point-of-care measurement of activated clotting time for cardiac surgery as measured by the Hemochron signature elite and the Abbott i-STAT: agreement, concordance, and clinical reliabilityBMC Anesthesiology, 2019
- Comparison of Point-of-Care Activated Clotting Time Methods in Different Clinical Settings in a Large Academic Medical CenterThe Journal of Applied Laboratory Medicine, 2017
- Clinical Evaluation of the i-STAT Kaolin Activated Clotting Time (ACT) Test in Different Clinical Settings in a Large Academic Urban Medical CenterAmerican Journal of Clinical Pathology, 2011
- Comparison of the i-STAT handheld activated clotting time with the Hemochron activated clotting time during and after percutaneous coronary interventionThe American Journal of Cardiology, 2003